Potentially inappropriate medications in older adults with Parkinson disease before and after hospitalization for injury

被引:1
作者
Nguyen, Thanh Phuong Pham [1 ,2 ,3 ,4 ]
Gray, Shelly L. [5 ]
Newcomb, Craig W. [3 ]
Liu, Qing [3 ]
Hamedani, Ali G. [1 ,2 ,3 ]
Weintraub, Daniel [6 ,7 ,8 ]
Hennessy, Sean [2 ,3 ,4 ]
Willis, Allison W. [1 ,2 ,3 ,4 ,7 ,8 ]
机构
[1] Univ Penn, Translat Ctr Excellence Neuroepidemiol & Neurol Ou, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA USA
[3] Univ Penn, Ctr Real World Effectiveness & Safety Therapeut, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA USA
[4] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA USA
[5] Univ Washington, Sch Pharm, Dept Pharm, Seattle, WA USA
[6] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA USA
[7] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA USA
[8] Corporal Michael J Crescenz VA Med Ctr, Parkinsons Dis Res Educ & Clin Ctr, Philadelphia, PA USA
基金
美国国家卫生研究院;
关键词
Parkinson disease; Potentially inappropriate medication; Fall-risk-increasing drug; Unintentional traumatic injury; Fall-related fracture; RECURRENT FALLS; HEALTH; RISK;
D O I
10.1016/j.parkreldis.2023.105793
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Parkinson disease (PD) patients are at increased risk of serious injury, such as fall-related fractures. Prescription medications are a modifiable factor for injury risk.Objectives: To determine the extent to which a serious injury requiring hospitalization affects prescribing of potentially inappropriate medications (PIMs) among older adults with PD. Methods: We conducted a quasi-experimental difference-in-difference (DID) study using 2013-2017 Medicare data. The cohort consisted of beneficiaries with PD hospitalized for injury versus for other reasons. PIMs were classified into PD and injury-relevant categories (CNS-active PIMs, PD motor symptom PIMs, PD non-motor symptom PIMs, PIMs that reduce bone mineral density). We estimated mean standardized daily doses (SDDs) of medications within each PIM category before and at 3, 6, and 12 months after hospitalization. We used generalized linear regression models to compare changes in mean SDDs for each PIM category between the injury and non-injury group at each timepoint, adjusting for biological, clinical and social determinants of health variables. Results: Both groups discontinued PIMs and/or reduced PIM doses after hospitalization. There were no between -group differences in mean SDD changes, after covariate adjustment, for any PIM category, except for the CNS-active PIMs category at 3 months (DID p-value = 0.00) and for the category of PIMs that reduce bone mineral density at all timepoints (DID p-values = 0.02, 0.04, 0.02 at 3, 6, and 12 months).Conclusions: Similar patterns of PIM among persons with PD after hospitalization for serious injury versus for other reasons may represent a missed opportunity to deprescribe high-risk medications during care transitions.
引用
收藏
页数:7
相关论文
共 31 条
[1]  
Aarsland D, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00280-3
[2]   Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction A Cohort Study [J].
Booth, John N., III ;
Colantonio, Lisandro D. ;
Chen, Ligong ;
Rosenson, Robert S. ;
Monda, Keri L. ;
Safford, Monika M. ;
Kilgore, Meredith L. ;
Brown, Todd M. ;
Taylor, Benjamin ;
Dent, Ricardo ;
Muntner, Paul ;
Levitan, Emily B. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2017, 10 (10)
[3]   Measures of Social Deprivation That Predict Health Care Access and Need within a Rational Area of Primary Care Service Delivery [J].
Butler, Danielle C. ;
Petterson, Stephen ;
Phillips, Robert L. ;
Bazemore, Andrew W. .
HEALTH SERVICES RESEARCH, 2013, 48 (02) :539-559
[4]   A Validation Study of Administrative Data Algorithms to Identify Patients with Parkinsonism with Prevalence and Incidence Trends [J].
Butt, Debra A. ;
Tu, Karen ;
Young, Jacqueline ;
Green, Diane ;
Wang, Myra ;
Ivers, Noah ;
Jaakkimainen, Liisa ;
Lam, Robert ;
Guttman, Mark .
NEUROEPIDEMIOLOGY, 2014, 43 (01) :28-37
[5]  
Canning CG, 2014, NEURODEGENER DIS MAN, V4, P203, DOI [10.2217/nmt.14.22, 10.2217/NMT.14.22]
[6]   Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease [J].
Crispo, James A. G. ;
Willis, Allison W. ;
Thibault, Dylan P. ;
Fortin, Yannick ;
Hays, Harlen D. ;
McNair, Douglas S. ;
Bjerre, Lise M. ;
Kohen, Dafna E. ;
Perez-Lloret, Santiago ;
Mattison, Donald R. ;
Krewski, Daniel .
PLOS ONE, 2016, 11 (03)
[7]   Polypharmacy in Parkinson's disease: risks and benefits with little evidence [J].
Csoti, I. ;
Herbst, H. ;
Urban, P. ;
Woitalla, D. ;
Wuellner, U. .
JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (07) :871-878
[8]   Signals of Muscle Relaxant Drug Interactions Associated with Unintentional Traumatic Injury: A Population-Based Screening Study [J].
Dawwas, Ghadeer K. ;
Hennessy, Sean ;
Brensinger, Colleen M. ;
Acton, Emily K. ;
Bilker, Warren B. ;
Chung, Sophie ;
Dublin, Sascha ;
Horn, John R. ;
Manis, Melanie M. ;
Miano, Todd A. ;
Oslin, David W. ;
Nguyen, Thanh Phuong Pham ;
Soprano, Samantha E. ;
Wiebe, Douglas J. ;
Leonard, Charles E. .
CNS DRUGS, 2022, 36 (04) :389-400
[9]   Falls in Parkinson's Disease: A Complex and Evolving Picture [J].
Fasano, Alfonso ;
Canning, Colleen G. ;
Hausdorff, Jeffrey M. ;
Lord, Sue ;
Rochester, Lynn .
MOVEMENT DISORDERS, 2017, 32 (11) :1524-1536
[10]   American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults [J].
Fick, Donna M. ;
Semla, Todd P. ;
Steinman, Michael ;
Beizer, Judith ;
Brandt, Nicole ;
Dombrowski, Robert ;
DuBeau, Catherine E. ;
Pezzullo, Lynn ;
Epplin, Jerome J. ;
Flanagan, Nina ;
Morden, Emily ;
Hanlon, Joseph ;
Hollmann, Peter ;
Laird, Rosemary ;
Linnebur, Sunny ;
Sandhu, Satinderpal .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 (04) :674-694